Advertisement

Index by author

February 01, 2017; Volume 91,Issue 2

A

  1. Aa, Jiye

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  2. Aa, Nan

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  3. Akk, Gustav

    1. The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484

B

  1. Bass, Caroline E.

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

  2. Bhatt, Tanya

    1. Dynamin Functions and Ligands: Classical Mechanisms Behind
      Mahaveer Singh, Hemant R. Jadhav and Tanya Bhatt
      Molecular Pharmacology February 2017, 91 (2) 123-134; DOI: https://doi.org/10.1124/mol.116.105064

  3. Blume, Lawrence C.

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

  4. Bosnyak, Sanja

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

  5. Brady, Ryan

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

C

  1. Campbell, Adrian P.

    1. Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors
      Adrian P. Campbell, Laurence P. G. Wakelin, William A. Denny and Angela M. Finch
      Molecular Pharmacology February 2017, 91 (2) 135-144; DOI: https://doi.org/10.1124/mol.116.105874

  2. Cao, Bei

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  3. Charman, William N.

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

  4. Chen, Qiang

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  5. Christopoulos, Arthur

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

  6. Cook, Anna E.

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

D

  1. Denny, William A.

    1. Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors
      Adrian P. Campbell, Laurence P. G. Wakelin, William A. Denny and Angela M. Finch
      Molecular Pharmacology February 2017, 91 (2) 135-144; DOI: https://doi.org/10.1124/mol.116.105874

  2. Diepenhorst, Natalie A.

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

E

  1. Eldeeb, Khalil

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

F

  1. Fei, Fei

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  2. Feng, Dong

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  3. Feng, Siqi

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  4. Finch, Angela M.

    1. Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors
      Adrian P. Campbell, Laurence P. G. Wakelin, William A. Denny and Angela M. Finch
      Molecular Pharmacology February 2017, 91 (2) 135-144; DOI: https://doi.org/10.1124/mol.116.105874

G

  1. Ge, Chun

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  2. Germann, Allison L.

    1. The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484

  3. Guo, Grace L.

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  4. Guo, Jiahua

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

H

  1. Hantgan, Roy R.

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

  2. He, Jun

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  3. Howlett, A­llyn C.

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

  4. Huang, Jingqiu

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

I

  1. Ilyasov, Alexander A.

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

J

  1. Jadhav, Hemant R.

    1. Dynamin Functions and Ligands: Classical Mechanisms Behind
      Mahaveer Singh, Hemant R. Jadhav and Tanya Bhatt
      Molecular Pharmacology February 2017, 91 (2) 123-134; DOI: https://doi.org/10.1124/mol.116.105064

  2. Jin, Xiaochun

    1. The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484

  3. Johnson, Jeffrey R.

    1. G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

K

  1. Keegan, Bradley M.

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

  2. Kong, Bo

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  3. Krogan, Nevan J.

    1. G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

L

  1. Langmead, Christopher J.

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

  2. Leone-Kabler, Sandra

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

  3. Lowther, W. Todd

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

M

  1. Mannoury la Cour, Clotilde

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

  2. McCollum, Megan M.

    1. The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484

  3. Mocaer, Elisabeth

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

N

  1. Newton, Billy W.

    1. G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

O

  1. O’Neal, Jeremy E.

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

P

  1. Pan, Yang

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  2. Patten, Theresa

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

R

  1. Riddy, Darren M.

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

  2. Riordan, Daniel P.

    1. G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

S

  1. Schumacher, Justin D.

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  2. Selley, Dana E.

    1. Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites
      Lawrence C. Blume, Theresa Patten, Khalil Eldeeb, Sandra Leone-Kabler, Alexander A. Ilyasov, Bradley M. Keegan, Jeremy E. O’Neal, Caroline E. Bass, Roy R. Hantgan, W. Todd Lowther, Dana E. Selley and A­llyn C. Howlett
      Molecular Pharmacology February 2017, 91 (2) 75-86; DOI: https://doi.org/10.1124/mol.116.104638

  3. Sexton, Patrick M.

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

  4. Shen, Jianliang

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  5. Singh, Mahaveer

    1. Dynamin Functions and Ligands: Classical Mechanisms Behind
      Mahaveer Singh, Hemant R. Jadhav and Tanya Bhatt
      Molecular Pharmacology February 2017, 91 (2) 123-134; DOI: https://doi.org/10.1124/mol.116.105064

  6. Steinbach, Joe Henry

    1. The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors
      Xiaochun Jin, Megan M. McCollum, Allison L. Germann, Gustav Akk and Joe Henry Steinbach
      Molecular Pharmacology February 2017, 91 (2) 100-109; DOI: https://doi.org/10.1124/mol.116.106484

  7. Summers, Roger J.

    1. Isoform-Specific Biased Agonism of Histamine H3 Receptor Agonists
      Darren M. Riddy, Anna E. Cook, Natalie A. Diepenhorst, Sanja Bosnyak, Ryan Brady, Clotilde Mannoury la Cour, Elisabeth Mocaer, Roger J. Summers, William N. Charman, Patrick M. Sexton, Arthur Christopoulos and Christopher J. Langmead
      Molecular Pharmacology February 2017, 91 (2) 87-99; DOI: https://doi.org/10.1124/mol.116.106153

  8. Sun, Runbin

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  9. Sundaram, Aparna B.

    1. G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

T

  1. Trester-Zedlitz, Michelle

    1. G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

  2. Tsvetanova, Nikoleta G.

    1. G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

V

  1. von Zastrow, Mark

    1. G Protein–Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands
      Nikoleta G. Tsvetanova, Michelle Trester-Zedlitz, Billy W. Newton, Daniel P. Riordan, Aparna B. Sundaram, Jeffrey R. Johnson, Nevan J. Krogan and Mark von Zastrow
      Molecular Pharmacology February 2017, 91 (2) 145-156; DOI: https://doi.org/10.1124/mol.116.106369

W

  1. Wakelin, Laurence P. G.

    1. Homobivalent Conjugation Increases the Allosteric Effect of 9-aminoacridine at the α1-Adrenergic Receptors
      Adrian P. Campbell, Laurence P. G. Wakelin, William A. Denny and Angela M. Finch
      Molecular Pharmacology February 2017, 91 (2) 135-144; DOI: https://doi.org/10.1124/mol.116.105874

  2. Wang, Guangji

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  3. Wang, Pei

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

Y

  1. Yang, Chung S.

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  2. Yang, Na

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617

  3. Yu, Xiaoyi

    1. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway
      Runbin Sun, Na Yang, Bo Kong, Bei Cao, Dong Feng, Xiaoyi Yu, Chun Ge, Jingqiu Huang, Jianliang Shen, Pei Wang, Siqi Feng, Fei Fei, Jiahua Guo, Jun He, Nan Aa, Qiang Chen, Yang Pan, Justin D. Schumacher, Chung S. Yang, Grace L. Guo, Jiye Aa and Guangji Wang
      Molecular Pharmacology February 2017, 91 (2) 110-122; DOI: https://doi.org/10.1124/mol.116.106617
Back to top

In this issue

Advertisement